Mitchell Glass
Net worth: 54 625 $ as of 31/05/2026
Net worth: 54 625 $ as of 31/05/2026
Mitchell Glass is currently Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd., Chairman at Accolade Pharma LLC, Director at Orphagenix, Inc., Director at Avatar Biotechnologies LLC, and Director & Chief Medical Officer at Q.
Former roles include Chief Executive Officer at Aqumen Biopharmaceuticals KK, Chief Executive Officer at Aqumen Biopharmaceuticals NA, Inc., Director & Vice President at GlaxoSmithKline LLC, Executive Director & Chief Medical Officer at Invion Ltd., Chief Medical Officer & VP-Regulatory Affairs at AtheroGenics, Inc., Principal at the University of Pennsylvania, Chief Scientific Officer at University City Science Center, Principal at AstraZeneca, Inc., Principal at Inverseon, Inc., and Chief Medical Officer & EVP-Research & Development at Invion Ltd. Education includes undergraduate and doctorate degrees from The University of Chicago, conferred in 1973 and 1977 respectively.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/04/2026 | 12,500 ( 0.16% ) | 54 625 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| Q/C TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 14/06/2024 |
Accolade Pharma LLC
Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chairman | - |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Chief Executive Officer | - |
Avatar Biotechnologies LLC | Director/Board Member | 13/04/2010 |
Orphagenix, Inc. | Director/Board Member | 13/04/2010 |
| Companies | Position | End |
|---|---|---|
| INVION LIMITED | Chief Tech/Sci/R&D Officer | 01/03/2019 |
| INVION LIMITED | Director/Board Member | 12/02/2019 |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Corporate Officer/Principal | 01/09/2012 |
Aqumen Biopharmaceuticals NA, Inc. | President | 02/01/2008 |
| ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 15 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Orphagenix, Inc. | |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Aqumen Biopharmaceuticals NA, Inc. | |
Avatar Biotechnologies LLC | |
Invion Ltd.
Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Accolade Pharma LLC
Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
MyMD Pharmaceuticals, Inc.
MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions